Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2011-05-05 19:23 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the reinforc…
|
English | 152.5 KB | ||
| 2011-05-05 19:10 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce son chiffre d’af…
|
French | 139.0 KB | ||
| 2011-05-05 19:10 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces its turnover for t…
|
English | 137.1 KB | ||
| 2011-05-04 17:50 |
Innate Pharma et Transgene annoncent la création de Platine Pharma Services, no…
|
French | 441.4 KB | ||
| 2011-05-04 17:50 |
Innate Pharma and Transgene Announce the Creation of Platine Pharma Services, a…
|
English | 460.5 KB | ||
| 2011-05-03 00:00 |
Innate Pharma (Euronext Paris : FR0010331421 – IPH) annonce la mise à dispositi…
|
French | 29.6 KB | ||
| 2011-05-03 00:00 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces that the French ve…
|
English | 29.6 KB | ||
| 2011-05-02 21:39 |
DOCUMENT DE REFERENCE ET RAPPORT FINANCIER ANNUEL, INNATE PHARMA SA
|
French | 1.4 MB | ||
| 2011-03-23 17:47 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) fait le point sur ses pr…
|
French | 33.4 KB | ||
| 2011-03-23 17:47 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) updates on its next meetings…
|
English | 160.3 KB | ||
| 2011-03-02 00:10 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce ses résultats po…
|
French | 94.8 KB | ||
| 2011-03-02 00:10 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) reports 2010 financial resul…
|
English | 96.1 KB | ||
| 2011-02-28 17:51 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) receives a milestone payment…
|
English | 161.7 KB | ||
| 2011-02-28 17:51 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) reçoit un paiement d’étap…
|
French | 219.0 KB | ||
| 2011-02-04 17:45 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce des produits opé…
|
French | 39.1 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
